Core Viewpoint - Precision Optics Corporation reported its second quarter fiscal year 2025 results, highlighting a significant production growth driven by new applications and defense/aerospace programs, despite a decline in engineering revenue due to R&D investments [4][5]. Financial Highlights - Revenue for Q2 2025 was $4.5 million, a decrease from $4.8 million in Q2 2024 but an 8% increase from $4.2 million in the previous quarter [5][6]. - Production revenue reached $3.3 million, up 42% sequentially from $2.3 million and compared to $2.6 million in the same quarter last year [5][6]. - Engineering revenue fell to $1.2 million from $2.3 million year-over-year and $1.9 million sequentially [5][6]. - Gross margins were reported at 23.6%, down from 30.1% in the same quarter last year and 26.6% sequentially [5][6]. - The net loss for the quarter was $1.0 million, compared to a loss of $0.8 million in the same quarter last year and $1.3 million in the previous quarter [5][6]. Recent Developments - The company launched the Unity Imaging Platform in January 2025, aimed at transforming endoscopic imaging device development by reducing costs and time to market [5][6]. - A $340,000 production order was received from a global medical device company for a new single-use ophthalmic endoscope, with expectations for follow-on orders [5][6]. - Following FDA clearance for a single-use urological endoscope, the company accelerated production against a $9 million order, estimating $2.7 million in product deliveries for the fiscal year ending June 2025 [5][6]. Operational Insights - Production growth was noted as the highest since the end of fiscal 2023, with expectations for continued revenue growth in the second half of fiscal 2025 [4][5]. - The company anticipates improvements in gross margin and net income due to a large backlog of production programs and engineering projects [4][5].
Precision Optics Reports Second Quarter Fiscal Year 2025 Financial Results